Aptus Capital Advisors, LLC Amgen Inc Call Options Transaction History

Aptus Capital Advisors, LLC

  • $4.95 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Oct 19, 2020
BUY
$234.65 - $260.95 $4.46 Million - $4.96 Million
19,000 Added 37.25%
70,000 $17.8 Million
Q4 2019

Feb 10, 2020
BUY
$189.21 - $243.2 $9.61 Million - $12.3 Million
50,770 Added 22073.91%
51,000 $12.3 Million
Q4 2018

Feb 12, 2019
BUY
$178.4 - $208.25 $41,032 - $47,897
230 New
230 $258,000

Others Institutions Holding AMGN

# of Institutions
2,933
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email